Mangoceuticals, Inc. (NASDAQ: MGRX), operating under the MangoRx and PeachesRx brands, has reported significant initial success for its newly launched all-inclusive injectable testosterone replacement therapy program priced at $99 per month. The program includes doctor visits, consultations, lab work and prescribed medication. Since launching in mid-December, month-over-month sales of the injectable TRT program have increased 336% while customer acquisition costs declined 54%.
The company described these results as reflecting growing demand for convenient hormone health solutions delivered through its telehealth platform. MangoRx expects TRT to serve as a primary growth driver, alongside oral formulations including PRIME by MangoRx powered by Kyzatrex, as it seeks to expand its presence in the global TRT market. This market is estimated at approximately $2.1 billion to $2.2 billion in 2025.
MangoRx is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. The company currently offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction, hair growth, hormone replacement therapies, and weight management. Interested consumers can use MangoRx's telemedicine platform for a smooth experience where prescription requests are reviewed by a licensed medical provider and, if approved, fulfilled and discreetly shipped through MangoRx's partner compounding pharmacy directly to the patient's doorstep.
The announcement was made through BioMedWire, a specialized communications platform with a focus on the latest developments in the Biotechnology, Biomedical Sciences and Life Sciences sectors. BioMedWire is one of 75+ brands within the Dynamic Brand Portfolio at IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach target markets. The platform also provides article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions. For more information about BioMedWire, please visit https://www.BioMedWire.com. To learn more about MangoRx's mission and other products, please visit https://www.MangoRx.com.
